Hong Kong Stock Market Pulse | Jinhai Med Tech Surges Nearly 8% in Morning Session as Southbound Holdings Climb Rapidly and H1 Revenue Mix Improves Markedly

Stock News09-21

JINHAI MED TECH (02225) climbed nearly 8% during the morning trading session on the Hong Kong Stock Exchange. As of the time of writing, the stock was up 5.00% at HKD 5.98, with a trading turnover of HKD 15.31 million.

On the news front, on September 7, JINHAI MED TECH was officially included in the Hang Seng Stock Connect list. This inclusion is expected to broaden the shareholder base, attract long-term institutional investors, and enhance the liquidity of share trading.

Data indicates that southbound capital has been consistently increasing its stake in the company. The proportion of shares held via the Stock Connect program rose rapidly from 0.3% on September 10 to 0.7% by September 18. Notably, the company's revenue structure saw significant optimization in the first half of the year.

Revenue from minimally invasive surgical solutions and medical products reached SGD 25.43 million, a year-on-year surge of 301.5%, accounting for 74.73% of total revenue, with all of it originating from the Chinese market. Financial reports also revealed that the company accrued corporate income tax in China for the first time this period, signaling that JINHAI MED TECH's medical business in China has crossed the operational breakeven threshold.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150922372?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-21 10:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150922372","market":"other","top_or_hot":-1,"title":"Hong Kong Stock Market Pulse | Jinhai Med Tech Surges Nearly 8% in Morning Session as Southbound Holdings Climb Rapidly and H1 Revenue Mix Improves Markedly","media":"Stock News","content":"<p><b>JINHAI MED TECH</b> (02225) climbed nearly 8% during the morning trading session on the Hong Kong Stock Exchange. As of the time of writing, the stock was up 5.00% at HKD 5.98, with a trading turnover of HKD 15.31 million.<br><br>On the news front, on September 7, <b>JINHAI MED TECH</b> was officially included in the Hang Seng Stock Connect list. This inclusion is expected to broaden the shareholder base, attract long-term institutional investors, and enhance the liquidity of share trading.<br><br>Data indicates that southbound capital has been consistently increasing its stake in the company. The proportion of shares held via the Stock Connect program rose rapidly from 0.3% on September 10 to 0.7% by September 18. Notably, the company's revenue structure saw significant optimization in the first half of the year.<br><br>Revenue from minimally invasive surgical solutions and medical products reached SGD 25.43 million, a year-on-year surge of 301.5%, accounting for 74.73% of total revenue, with all of it originating from the Chinese market. Financial reports also revealed that the company accrued corporate income tax in China for the first time this period, signaling that <b>JINHAI MED TECH</b>'s medical business in China has crossed the operational breakeven threshold.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stock Market Pulse | Jinhai Med Tech Surges Nearly 8% in Morning Session as Southbound Holdings Climb Rapidly and H1 Revenue Mix Improves Markedly</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stock Market Pulse | Jinhai Med Tech Surges Nearly 8% in Morning Session as Southbound Holdings Climb Rapidly and H1 Revenue Mix Improves Markedly\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-21 10:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>JINHAI MED TECH</b> (02225) climbed nearly 8% during the morning trading session on the Hong Kong Stock Exchange. As of the time of writing, the stock was up 5.00% at HKD 5.98, with a trading turnover of HKD 15.31 million.<br><br>On the news front, on September 7, <b>JINHAI MED TECH</b> was officially included in the Hang Seng Stock Connect list. This inclusion is expected to broaden the shareholder base, attract long-term institutional investors, and enhance the liquidity of share trading.<br><br>Data indicates that southbound capital has been consistently increasing its stake in the company. The proportion of shares held via the Stock Connect program rose rapidly from 0.3% on September 10 to 0.7% by September 18. Notably, the company's revenue structure saw significant optimization in the first half of the year.<br><br>Revenue from minimally invasive surgical solutions and medical products reached SGD 25.43 million, a year-on-year surge of 301.5%, accounting for 74.73% of total revenue, with all of it originating from the Chinese market. Financial reports also revealed that the company accrued corporate income tax in China for the first time this period, signaling that <b>JINHAI MED TECH</b>'s medical business in China has crossed the operational breakeven threshold.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"","article_id":"1150922372","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150922372","pubTimestamp":1789959014,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"JINHAI MED TECH (02225) climbed nearly 8% during the morning trading session on the Hong Kong Stock Exchange. As of the time of writing, the stock was up 5.00% at HKD 5.98, with a trading turnover of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","FLHK":"Franklin FTSE Hong Kong ETF","BK4585":"ETF&股票定投概念","VXUS":"国际股票ETF-Vanguard","02225":"今海医疗科技","KCAI":"KraneShares China Alpha Index ETF","BK1150":"人力资源与就业服务"},"translate_title":"港股脉搏|金海医疗科技早盘大涨近8%，南向持股快速攀升，上半年营收组合明显改善","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1,"02225":1,"FLHK":1,"KCAI":1},"content_text":"JINHAI MED TECH (02225) climbed nearly 8% during the morning trading session on the Hong Kong Stock Exchange. As of the time of writing, the stock was up 5.00% at HKD 5.98, with a trading turnover of HKD 15.31 million.On the news front, on September 7, JINHAI MED TECH was officially included in the Hang Seng Stock Connect list. This inclusion is expected to broaden the shareholder base, attract long-term institutional investors, and enhance the liquidity of share trading.Data indicates that southbound capital has been consistently increasing its stake in the company. The proportion of shares held via the Stock Connect program rose rapidly from 0.3% on September 10 to 0.7% by September 18. Notably, the company's revenue structure saw significant optimization in the first half of the year.Revenue from minimally invasive surgical solutions and medical products reached SGD 25.43 million, a year-on-year surge of 301.5%, accounting for 74.73% of total revenue, with all of it originating from the Chinese market. Financial reports also revealed that the company accrued corporate income tax in China for the first time this period, signaling that JINHAI MED TECH's medical business in China has crossed the operational breakeven threshold.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150922372","isCrawlerRequest":true}